PMC:7073332 / 499-1189
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
47 | 289-294 | Species | denotes | human | Tax:9606 |
48 | 391-400 | Species | denotes | 2019-nCoV | Tax:2697049 |
49 | 401-411 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
50 | 465-473 | Species | denotes | SARS-CoV | Tax:694009 |
51 | 539-548 | Species | denotes | 2019-nCoV | Tax:2697049 |
52 | 549-559 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
53 | 677-685 | Species | denotes | SARS-CoV | Tax:694009 |
59 | 243-247 | Species | denotes | HCoV | Tax:694448 |
60 | 360-364 | Species | denotes | HCoV | Tax:694448 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 295-302 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 303-310 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 371-378 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
T4 | 431-441 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T5 | 527-535 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 401-409 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 465-473 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 549-557 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 677-685 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 149-150 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 289-302 | http://purl.obolibrary.org/obo/PR_000029067 | denotes | human protein |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 39-43 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6 | 97-111 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T7 | 97-106 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T8 | 107-111 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T9 | 186-194 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
T10 | 269-273 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T11 | 295-302 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T12 | 303-310 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T13 | 431-441 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T14 | 527-535 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 55-331 | Sentence | denotes | In this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV–host interactome and drug targets in the human protein–protein interaction network. |
T7 | 332-482 | Sentence | denotes | Phylogenetic analyses of 15 HCoV whole genomes reveal that 2019-nCoV/SARS-CoV-2 shares the highest nucleotide sequence identity with SARS-CoV (79.7%). |
T8 | 483-686 | Sentence | denotes | Specifically, the envelope and nucleocapsid proteins of 2019-nCoV/SARS-CoV-2 are two evolutionarily conserved regions, having the sequence identities of 96% and 89.6%, respectively, compared to SARS-CoV. |